BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 25027687)

  • 41. Prognostic role of preoperative albumin to globulin ratio in predicting survival of clear cell renal cell carcinoma.
    Koparal MY; Polat F; Çetin S; Bulut EC; Sözen TS
    Int Braz J Urol; 2018; 44(5):933-946. PubMed ID: 29757575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated preoperative plasma D-dimer level is a useful predictor of chemoresistance and poor disease outcome for serous ovarian cancer patients.
    Liu P; Wang Y; Tong L; Xu Y; Zhang W; Guo Z; Ni H
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1163-71. PubMed ID: 26542279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
    Klatte T; Seligson DB; LaRochelle J; Shuch B; Said JW; Riggs SB; Zomorodian N; Kabbinavar FF; Pantuck AJ; Belldegrun AS
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):894-900. PubMed ID: 19240241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Establishment of a Nomogram-Based Model for Predicting the Prognostic Value of Inflammatory Biomarkers and Preoperative D-Dimer Level in Spinal Ewing's Sarcoma Family Tumors: A Retrospective Study of 83 Patients.
    Xu K; Lou Y; Sun R; Liu Y; Li B; Li J; Huang Q; Wan W; Xiao J
    World Neurosurg; 2019 Jan; 121():e104-e112. PubMed ID: 30218803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in papillary renal cell carcinoma patients after receiving curative surgery based on a retrospective cohort.
    Zhang Z; Yu Y; Zheng J; Zhang M; Niu H
    BMC Urol; 2021 Mar; 21(1):43. PubMed ID: 33752642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.
    Isbarn H; Patard JJ; Lughezzani G; Rioux-Leclercq N; Crépel M; Cindolo L; de la Taille A; Zini L; Villers A; Shariat SF; Bertini R; Karakiewicz PI
    Urology; 2010 Jun; 75(6):1378-84. PubMed ID: 19781745
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statin Use and Serum Lipid Levels Are Associated With Survival Outcomes After Surgery for Renal Cell Carcinoma.
    Haddad AQ; Jiang L; Cadeddu JA; Lotan Y; Gahan JC; Hynan LS; Gupta N; Raj GV; Sagalowsky AI; Margulis V
    Urology; 2015 Dec; 86(6):1146-52. PubMed ID: 26416007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An elevated preoperative plasma fibrinogen level is associated with poor disease-specific and overall survival in breast cancer patients.
    Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
    Breast; 2015 Oct; 24(5):667-72. PubMed ID: 26346586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preoperative Gamma-Glutamyltransferase Is Associated with Cancer-Specific Survival and Recurrence-Free Survival of Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus.
    Luo C; Xu B; Fan Y; Yu W; Zhang Q; Jin J
    Biomed Res Int; 2017; 2017():3142926. PubMed ID: 28168196
    [No Abstract]   [Full Text] [Related]  

  • 50. Prognosis and characteristics of renal cell carcinoma in hemodialysis patients: bilateral occurrence does not influence cancer-specific survival.
    Takagi T; Kondo T; Izuka J; Kobayashi H; Tomita E; Hashimoto Y; Tanabe K
    Int J Urol; 2011 Dec; 18(12):806-12. PubMed ID: 21917022
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to Nephrectomy.
    Tsujino T; Komura K; Matsunaga T; Yoshikawa Y; Takai T; Uchimoto T; Saito K; Tanda N; Oide R; Minami K; Uehara H; Jeong SH; Taniguchi K; Hirano H; Nomi H; Ibuki N; Takahara K; Inamoto T; Azuma H
    Ann Surg Oncol; 2017 Sep; 24(9):2787-2793. PubMed ID: 28643013
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preoperative serum cholesterol is an independent prognostic factor for patients with renal cell carcinoma (RCC).
    de Martino M; Leitner CV; Seemann C; Hofbauer SL; Lucca I; Haitel A; Shariat SF; Klatte T
    BJU Int; 2015 Mar; 115(3):397-404. PubMed ID: 24698164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance of high nuclear grade in patients with pathologic T1a renal cell carcinoma.
    Suzuki K; Mizuno R; Mikami S; Tanaka N; Kanao K; Kikuchi E; Miyajima A; Nakagawa K; Oya M
    Jpn J Clin Oncol; 2012 Sep; 42(9):831-5. PubMed ID: 22811408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Relationship Between Red Cell Distribution Width and Cancer-Specific Survival in Patients With Renal Cell Carcinoma Treated With Partial and Radical Nephrectomy.
    Życzkowski M; Rajwa P; Gabrys E; Jakubowska K; Jantos E; Paradysz A
    Clin Genitourin Cancer; 2018 Jun; 16(3):e677-e683. PubMed ID: 29339043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glucose-regulated protein 78 positivity as a predictor of poor survival in patients with renal cell carcinoma.
    Kuroda K; Horiguchi A; Asano T; Ito K; Asakuma J; Sato A; Yoshii H; Hayakawa M; Sumitomo M; Asano T
    Urol Int; 2011; 87(4):450-6. PubMed ID: 22076227
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma.
    de Martino M; Pantuck AJ; Hofbauer S; Waldert M; Shariat SF; Belldegrun AS; Klatte T
    J Urol; 2013 Dec; 190(6):1999-2004. PubMed ID: 23831313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
    Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
    Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis.
    Choi Y; Park B; Jeong BC; Seo SI; Jeon SS; Choi HY; Adami HO; Lee JE; Lee HM
    Int J Cancer; 2013 Feb; 132(3):625-34. PubMed ID: 22610826
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
    Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
    BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.